New registry aims to unlock secrets of rare leukemia
NCT ID NCT02560883
First seen Jul 02, 2026 ยท Last updated Jul 02, 2026
Summary
This study creates a registry for people with hairy cell leukemia (HCL), a rare form of adult leukemia. Researchers will track disease course, treatments, infections, and patient-reported outcomes over time. The goal is to identify trends, improve care, and design future clinical trials. Adults with classic or variant HCL can join.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors identify the best treatments and uncover hidden complications, ultimately improving survival and quality of life for people with this rare leukemia.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data but does not test any new therapy, so direct patient benefits may take years to emerge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAIRY CELL LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Cancer, Part of the Provincial Health Services Authority
RECRUITINGVancouver, Britsh Columbia, V5Z 4E6, Canada
-
Cancer Care Manitoba
RECRUITINGWinnipeg, Manitoba, R3E 0V9, Canada
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Mount Sinai Medical Center of Florida
RECRUITINGMiami Beach, Florida, 33140, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Peter MacCallum Cancer Center
RECRUITINGMelbourne, Victoria, VIC 3000, Australia
-
University of Miami/Soffer Clinical Research Center
RECRUITINGMiami, Florida, 33136, United States
-
University of Rochester /Wilmot Cancer Institute
RECRUITINGRochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can a Two-Drug combo beat back Tough-to-Treat hairy cell leukemia?
- New drug duo aims to tackle rare leukemia
- Engineered immune cells take aim at stubborn blood cancers
- New combo therapy targets rare blood cancer in early trial
- New combo aims to tame hairy cell leukemia with fewer side effects